These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8916146)

  • 21. Correlation between the number of apoptotic cells and expression of the apoptosis-related antigens Fas, Le(y) and bcl-2 protein in non-Hodgkin's lymphomas.
    Aftabuddin M; Yamadori I; Yoshino T; Kondo E; Akagi T
    Pathol Int; 1995 Jun; 45(6):422-9. PubMed ID: 7581933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis.
    Kim JH; Liu L; Lee SO; Kim YT; You KR; Kim DG
    Cancer Res; 2005 Jul; 65(14):6312-20. PubMed ID: 16024633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fas receptor is expressed in human lung squamous cell carcinomas, whereas bcl-2 and apoptosis are not pronounced: a preliminary report.
    Hellquist HB; Olejnicka B; Jadner M; Andersson T; Sederholm C
    Br J Cancer; 1997; 76(2):175-9. PubMed ID: 9231916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles.
    Sasaki M; Nakanuma Y; Ho SB; Kim YS
    Am J Clin Pathol; 1998 Mar; 109(3):302-8. PubMed ID: 9495202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The apoptosis protector, bcl-2 protein, is downregulated in bile duct epithelial cells of human liver allografts.
    Gapany C; Zhao M; Zimmermann A
    J Hepatol; 1997 Mar; 26(3):535-42. PubMed ID: 9075660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of p53 and c-myc expression and cell proliferation in human hepatocellular carcinomas--an enhanced immunohistochemical approach.
    Saegusa M; Takano Y; Kishimoto H; Wakabayashi G; Nohga K; Okudaira M
    J Cancer Res Clin Oncol; 1993; 119(12):737-44. PubMed ID: 8104947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of Bcl-2 protects human hepatoma cells from Fas-antibody-mediated apoptosis.
    Takahashi M; Saito H; Okuyama T; Miyashita T; Kosuga M; Sumisa F; Yamada M; Ebinuma H; Ishii H
    J Hepatol; 1999 Aug; 31(2):315-22. PubMed ID: 10453946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma.
    Qin HX; Nan KJ; Yang G; Jing Z; Ruan ZP; Li CL; Xu R; Guo H; Sui CG; Wei YC
    World J Gastroenterol; 2005 May; 11(18):2709-13. PubMed ID: 15884108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear translocation of survivin in hepatocellular carcinoma: a key to cancer cell growth?
    Moon WS; Tarnawski AS
    Hum Pathol; 2003 Nov; 34(11):1119-26. PubMed ID: 14652813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased expression of type II tumor suppressor gene RARRES3 in tissues of hepatocellular carcinoma and cholangiocarcinoma.
    Jiang SY; Chou JM; Leu FJ; Hsu YY; Shih YL; Yu JC; Lee MS; Shyu RY
    World J Gastroenterol; 2005 Feb; 11(7):948-53. PubMed ID: 15742394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptosis, cell proliferation and expression of oncogenes in gastric carcinomas induced by preoperative administration of 5-fluorouracil.
    Kimura H; Konishi K; Kaji M; Maeda K; Yabushita K; Tsuji M; Ogino H; Satomura Y; Unoura M; Miwa A
    Oncol Rep; 2000; 7(5):971-6. PubMed ID: 10948324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of combined hepatocellular-cholangiocarcinoma through transdifferentiation and dedifferentiation in p53-knockout mice.
    Liu Y; Xin B; Yamamoto M; Goto M; Ooshio T; Kamikokura Y; Tanaka H; Meng L; Okada Y; Mizukami Y; Nishikawa Y
    Cancer Sci; 2021 Aug; 112(8):3111-3124. PubMed ID: 34051011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical Assessment of the Expression of Biliary Transportation Proteins MRP2 and MRP3 in Hepatocellular Carcinoma and in Cholangiocarcinoma.
    Cirqueira CS; Felipe-Silva AS; Wakamatsu A; Marins LV; Rocha EC; de Mello ES; Alves VAF
    Pathol Oncol Res; 2019 Oct; 25(4):1363-1371. PubMed ID: 29464551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Fas system is not significantly involved in apoptosis in human hepatocellular carcinoma.
    Kubo K; Matsuzaki Y; Okazaki M; Kato A; Kobayashi N; Okita K
    Liver; 1998 Apr; 18(2):117-23. PubMed ID: 9588770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of bcl-2, p53 oncoprotein, and proliferating cell nuclear antigen in renal cell carcinoma.
    Sejima T; Miyagawa I
    Eur Urol; 1999; 35(3):242-8. PubMed ID: 10072628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19.
    Tsuji M; Kashihara T; Terada N; Mori H
    Pathol Int; 1999 Apr; 49(4):310-7. PubMed ID: 10365850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender and androgen treatment influence the expression of proto-oncogenes and apoptotic factors in lacrimal and salivary tissues of MRL/lpr mice.
    Toda I; Wickham LA; Sullivan DA
    Clin Immunol Immunopathol; 1998 Jan; 86(1):59-71. PubMed ID: 9434797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The potential role of bcl-2 mRNA and protein exression in hepatocellular carcinomas.
    Ravazoula P; Tsamandas AC; Kardamakis D; Gogos C; Karatza C; Thomopoulos K; Tepetes K; Kourelis T; Petsas T; Bonikos DS; Karavias D
    Anticancer Res; 2002; 22(3):1799-805. PubMed ID: 12168872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. c-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma.
    Terada T; Ashida K; Endo K; Horie S; Maeta H; Matsunaga Y; Takashima K; Ohta T; Kitamura Y
    Histopathology; 1998 Oct; 33(4):325-31. PubMed ID: 9822921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of pancreatic trypsinogen/trypsin and cathepsin B in human cholangiocarcinomas and hepatocellular carcinomas.
    Terada T; Ohta T; Minato H; Nakanuma Y
    Hum Pathol; 1995 Jul; 26(7):746-52. PubMed ID: 7628846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.